Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System
NAActive, not recruitingINTERVENTIONAL
Enrollment
4
Participants
Timeline
Start Date
April 30, 2014
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Conditions
Unresectable Pancreatic Cancer
Interventions
DEVICE
NanoKnife IRE System
Trial Locations (1)
21201
University of Maryland Medical Center, Baltimore
All Listed Sponsors
lead
University of Maryland, Baltimore
OTHER
NCT02041936 - Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System | Biotech Hunter | Biotech Hunter